Hutson Nancy J 4/A
4/A · PhaseBio Pharmaceuticals Inc · Filed May 20, 2022
Insider Transaction Report
Form 4/AAmended
Hutson Nancy J
Director
Transactions
- Purchase
Common Stock
2021-08-18$3.08/sh+3,000$9,240→ 4,000 total(indirect: Held in an individual retirement account for the benefit of the Reporting Person)
Holdings
- 33,760
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]Amended to report direct share ownership.